HARBIN, China, Feb. 25 /PRNewswire-Asia-FirstCall/ -- China Sky One Medical, Inc. ("China Sky One Medical" or "the Company") (Nasdaq: CSKI), a leading fully integrated pharmaceutical company producing over-the-counter drugs in the People's Republic of China ("PRC"), today announced that its wholly owned subsidiary, Harbin Tian Di Ren Medical Science and Technology Company, has expanded the sale of its Sumei Slim Patch into South Korea and Sudan. As a result, the product is now available in 26 countries and regions.
Following three months of market research, discussions and negotiations, China Sky One Medical has engaged PAX¡¤Medicare and Lai Li Investment Company as exclusive sales agents for the Sumei Slim Patch in South Korea and Sudan, respectively. The Slim Patch has passed the necessary examinations required in both countries and will be available to consumers shortly. China Sky One Medical's international sales team, PAX-Medicare and Lai Li Investment Company, is currently developing a detailed marketing plan that includes sales projections for the Slim Patch in both South Korea and in Sudan.
The Sumei Slim Patch is a proprietary weight loss product. Its main ingredients are extracted from Chinese herbs, which are healthy, natural and free of harmful side effects. Due to its effectiveness and safety, the Sumei Slim Patch is one of China Sky One Medical's best-selling products, and has received accolades from consumers in China and in other countries.
"We are pleased to expand sales of the Sumei Slim Patch into South Korea
and Sudan, which is a testament to the product's popularity and strong market
potential," said Mr. Yan-Qing Liu, Chairman and CEO of China Sky One Medical.
"It is well known that South Koreans spend money on keeping in shape, and we
expect Sumei Slim Patch to perform well in
'/>"/>
| SOURCE China Sky One Medical, Inc. Copyright©2009 PR Newswire. All rights reserved |